Thryve Partners with MSD Switzerland to Accelerate Early Diagnosis of Pulmonary Arterial Hypertension (PAH) with Health Data Insights
- Written by: Thryve
- 3 minutes
Berlin, December 4, 2024 – Thryve, a leader in digital health data integration and insights, is proud to announce its partnership with MSD Switzerland. This collaboration aims to develop innovative methods to enable earlier and faster diagnosis of pulmonary arterial hypertension (PAH), a rare and life-threatening condition often undiagnosed for extended periods.
This partnership was announced at the Kickstart Innovation 2024, one of Europe’s most prominent innovation platforms, fostering over 30 impactful deals in its latest program. By leveraging Thryve’s expertise in real-time digital biomarkers and data aggregation, combined with MSD’s deep clinical knowledge, the collaboration seeks to address the critical challenge of delayed diagnosis.
The Need for Innovation in PAH Diagnosis
Pulmonary arterial hypertension (PAH) is a progressive condition that affects the arteries in the lungs and the right side of the heart. Early detection is crucial for improving outcomes, yet PAH often remains undiagnosed.
“With the right tools and partnerships, we can identify undiagnosed patients, giving them a better chance at timely and effective treatment,” said Paul Burggraf, COO and Co-founder of Thryve.
Harnessing the Power of Digital Biomarkers
Thryve’s platform unifies data from wearables, smart devices, and medical sensors, turning fragmented health data into clinically meaningful insights. This capability is essential in the diagnosis and management of complex conditions like PAH, where early signs can be detected through subtle changes in health metrics.
“Digital biomarkers from patient generated data hold immense potential in transforming care pathways, especially in the first steps in the diagnostic funnel. By partnering with MSD, we are able to extend the scope of passive screening,” Burggraf added.
A Step Forward for Digital Health Innovation
This partnership underscores Thryve’s commitment to advancing digital health solutions that empower healthcare providers to make faster, data-driven decisions. By turning real-time health data into actionable insights, Thryve is helping to build a future where earlier diagnosis and personalized care are the norm.
About Thryve
Thryve is a leading provider of health and fitness tracker integration. The company offers an API-based engine that provides unified access and actionable insights from a diverse range of consumer health devices, improving results and saving integration costs for organizations across the healthcare industry. With a mission to build the standard infrastructure for 24/7 health data access and understanding, Thryve is at the forefront of preventative care and automated healthcare solutions. For more information, visit thryve.health .
